• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Special Transfusion Situations

Drone Delivery of Blood Products in South Africa

The South African National Blood Service (SANBS) in conjunction with the Western Cape Blood Service (WCBS) is preparing to test…

June 12, 2019

Severe Trauma Patients Should Receive Pre-hospital Blood Products

Severe trauma patients are at risk for hemorrhagic shock and death, and timely resuscitation is crucial for survival. The Prehospital…

April 24, 2019

Increased Mortality and Blood Product Use in Trauma Patients with Hypothermia

About half of all trauma patients experience hypothermia (body temperature less than 36°C), which leads to coagulopathy and poor health…

March 12, 2019

Anti-CD47 Interference with Serological Testing

Immunotherapy, the use of humanized monoclonal antibodies, is a promising therapy that works in conjunction with the patient’s own immune…

February 6, 2019

A New Drug for Patients with Thrombotic Thrombocytopenic Purpura

  Thrombotic thrombocytopenic purpura (TTP) is a rare disease in which autoimmune antibodies target ADAMTS13, a protease that cleaves the…

January 16, 2019

Whole Blood Transfusions on the Battlefield

Uncontrolled hemorrhage is life threatening for trauma victims, and transfusion of blood products along with hemorrhage control is critical for…

December 26, 2018

Older RBCs Associated with Increased Risk of Death Among Trauma Patients

Current regulations allow red blood cells (RBCs) to be stored and used for up to 42 days. During this time,…

November 27, 2018

Rituximab Treatment for Autoimmune Diseases

  Intravenous immune globin (IVIG) is used to treat immunoglobulin deficiency and autoimmune diseases.  However, other immune-modulating drugs, such as…

November 21, 2018

Eculizumab for Treating Cold Agglutinin Disease

Cold agglutinin disease (CAD) is a rare autoimmune disease caused by antibodies directed against red blood cell antigens, making them…

October 24, 2018

Red Cell Exchange for Patients with Sickle Cell Disease: an AABB Report

The Therapeutic Apheresis Subsection of the AABB, composed of 15 practicing apheresis physicians from 14 institutions, recently summarized how they…

September 12, 2018

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Interim pages omitted …
  • Page 13
  • Go to Next Page »

Primary Sidebar

Latest News

From Our Sponsor
  • Stop Sacrificing, Start Succeeding

  • Phase 1 Trial Results for Lentiviral Gene Therapy for Patients with Hemophilia A

  • Duffy-Null-Associated Neutrophil Counts in Oncology Patients with Febrile Neutropenia

  • Liberal versus Restrictive Transfusion Thresholds for Patients with Subarachnoid Hemorrhage

  • Blood Cell Salvage Decreases Transfusions After Decannulation from Extracorporeal Membrane Oxygenation (ECMO)

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley